BRPI1013731A2 - leite de crescimento contendo micro-organismos probioticos - Google Patents

leite de crescimento contendo micro-organismos probioticos

Info

Publication number
BRPI1013731A2
BRPI1013731A2 BRPI1013731A BRPI1013731A BRPI1013731A2 BR PI1013731 A2 BRPI1013731 A2 BR PI1013731A2 BR PI1013731 A BRPI1013731 A BR PI1013731A BR PI1013731 A BRPI1013731 A BR PI1013731A BR PI1013731 A2 BRPI1013731 A2 BR PI1013731A2
Authority
BR
Brazil
Prior art keywords
milk containing
probiotic microorganisms
containing probiotic
growing milk
growing
Prior art date
Application number
BRPI1013731A
Other languages
English (en)
Inventor
Mercenier Annick
Prioult Guenole
Nutten Sophie
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42646295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1013731(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP09159929A external-priority patent/EP2251022A1/en
Priority claimed from EP09159925A external-priority patent/EP2251020A1/en
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1013731A2 publication Critical patent/BRPI1013731A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/123—Bulgaricus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Sustainable Development (AREA)
BRPI1013731A 2009-05-11 2010-05-11 leite de crescimento contendo micro-organismos probioticos BRPI1013731A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09159929A EP2251022A1 (en) 2009-05-11 2009-05-11 Non-replicating micro-organisms and their immune boosting effect
EP09159925A EP2251020A1 (en) 2009-05-11 2009-05-11 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
PCT/EP2010/056399 WO2010133472A2 (en) 2009-05-11 2010-05-11 Growing up milks containing probiotic micro-organisms

Publications (1)

Publication Number Publication Date
BRPI1013731A2 true BRPI1013731A2 (pt) 2019-09-24

Family

ID=42646295

Family Applications (16)

Application Number Title Priority Date Filing Date
BRPI1014304A BRPI1014304A2 (pt) 2009-05-11 2010-05-07 bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
BRPI1012849A BRPI1012849A2 (pt) 2009-05-11 2010-05-07 lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
BRPI1010926A BRPI1010926A2 (pt) 2009-05-11 2010-05-11 fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI1010929A BRPI1010929A2 (pt) 2009-05-11 2010-05-11 fórmula de alimentação para bebê e crianças jovens compreendendo probióticos para bebês e crianças jovens.
BRPI1010919A BRPI1010919A2 (pt) 2009-05-11 2010-05-11 fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.
BRPI1010917A BRPI1010917A2 (pt) 2009-05-11 2010-05-11 nutrição líquida completa para crianças na idade de 1 a 10 anos compreendendo probióticos.
BRPI1010916A BRPI1010916A2 (pt) 2009-05-11 2010-05-11 fórmula nutricional especializada para pacientes adultos com intolerância gastrointestinal contendo probióticos.
BRPI1013731A BRPI1013731A2 (pt) 2009-05-11 2010-05-11 leite de crescimento contendo micro-organismos probioticos
BRPI1010912A BRPI1010912A2 (pt) 2009-05-11 2010-05-11 módulos contendo probióticos para alimentação por sonda.
BRPI1010836A BRPI1010836A2 (pt) 2009-05-11 2010-05-11 nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
BRPI1010839A BRPI1010839A2 (pt) 2009-05-11 2010-05-11 suplemento nutricional oral para crianças compreendendo probióticos
BRPI1010838A BRPI1010838A2 (pt) 2009-05-11 2010-05-11 espessante imediato compreendendo probióticos para alimentos e bebidas quentes ou frios a serem administrados a pacientes disfágicos
BRPI1010574A BRPI1010574A2 (pt) 2009-05-11 2010-05-11 cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI1010637-5A BRPI1010637A2 (pt) 2009-05-11 2010-05-11 suplementos nutricionais orais compreendendo probióticos
BRPI1010802A BRPI1010802A2 (pt) 2009-05-11 2010-05-11 preparações de leite integral seco contendo micro-organismos
BRPI1013733A BRPI1013733A2 (pt) 2009-05-11 2010-05-11 cereais do café da manhã contendo micro-organismos probióticos

Family Applications Before (7)

Application Number Title Priority Date Filing Date
BRPI1014304A BRPI1014304A2 (pt) 2009-05-11 2010-05-07 bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
BRPI1012849A BRPI1012849A2 (pt) 2009-05-11 2010-05-07 lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
BRPI1010926A BRPI1010926A2 (pt) 2009-05-11 2010-05-11 fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI1010929A BRPI1010929A2 (pt) 2009-05-11 2010-05-11 fórmula de alimentação para bebê e crianças jovens compreendendo probióticos para bebês e crianças jovens.
BRPI1010919A BRPI1010919A2 (pt) 2009-05-11 2010-05-11 fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.
BRPI1010917A BRPI1010917A2 (pt) 2009-05-11 2010-05-11 nutrição líquida completa para crianças na idade de 1 a 10 anos compreendendo probióticos.
BRPI1010916A BRPI1010916A2 (pt) 2009-05-11 2010-05-11 fórmula nutricional especializada para pacientes adultos com intolerância gastrointestinal contendo probióticos.

Family Applications After (8)

Application Number Title Priority Date Filing Date
BRPI1010912A BRPI1010912A2 (pt) 2009-05-11 2010-05-11 módulos contendo probióticos para alimentação por sonda.
BRPI1010836A BRPI1010836A2 (pt) 2009-05-11 2010-05-11 nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
BRPI1010839A BRPI1010839A2 (pt) 2009-05-11 2010-05-11 suplemento nutricional oral para crianças compreendendo probióticos
BRPI1010838A BRPI1010838A2 (pt) 2009-05-11 2010-05-11 espessante imediato compreendendo probióticos para alimentos e bebidas quentes ou frios a serem administrados a pacientes disfágicos
BRPI1010574A BRPI1010574A2 (pt) 2009-05-11 2010-05-11 cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI1010637-5A BRPI1010637A2 (pt) 2009-05-11 2010-05-11 suplementos nutricionais orais compreendendo probióticos
BRPI1010802A BRPI1010802A2 (pt) 2009-05-11 2010-05-11 preparações de leite integral seco contendo micro-organismos
BRPI1013733A BRPI1013733A2 (pt) 2009-05-11 2010-05-11 cereais do café da manhã contendo micro-organismos probióticos

Country Status (20)

Country Link
US (18) US8784798B2 (pt)
EP (16) EP2429538B1 (pt)
JP (16) JP2012526752A (pt)
CN (16) CN102802648A (pt)
AR (2) AR076676A1 (pt)
AU (3) AU2010247469B2 (pt)
BR (16) BRPI1014304A2 (pt)
CA (12) CA2761573A1 (pt)
CL (1) CL2011002818A1 (pt)
ES (4) ES2559008T3 (pt)
MX (7) MX338680B (pt)
MY (4) MY159273A (pt)
PL (2) PL2429557T3 (pt)
PT (2) PT2429539T (pt)
RU (6) RU2554772C2 (pt)
SG (1) SG175167A1 (pt)
TW (2) TWI489988B (pt)
UA (1) UA109876C2 (pt)
WO (16) WO2010130663A1 (pt)
ZA (4) ZA201109085B (pt)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784798B2 (en) 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2397145A1 (en) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2455094A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
SG191392A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
JP5821128B2 (ja) * 2011-02-18 2015-11-24 国立大学法人広島大学 大腸粘膜組織の免疫制御組成物
WO2012117065A1 (en) * 2011-03-01 2012-09-07 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
WO2012130965A1 (en) 2011-03-29 2012-10-04 Nestec S.A. Natural derivative of a well known and successful probiotic strain deficient in d-lactic acid production
BR112013025216A2 (pt) 2011-03-29 2018-09-04 Nestec S.A. derivado natural da cepa de lactobacillus johnsonii cncm i-1225 deficiente na produção de ácido d-láctico
MX2013011145A (es) 2011-03-29 2013-10-30 Nestec Sa Derivado natural de la cepa lactobacillus johnsonii cncm i-1225, deficiente en la produccion de acido d-lactico y con una vida util mejorada.
BR112013024831A2 (pt) 2011-03-29 2016-12-20 Nestec Sa derivado natural da cepa cncm i-1225 de lactobacillus johnsonii, deficiente na produção de ácido d=láctico e com um perfil imunológico mais incrementado
US20140030241A1 (en) * 2011-03-31 2014-01-30 Nestec S.A. Nutritional compositions for increasing arginine levels and methods of using same
PT3366143T (pt) * 2011-06-20 2025-01-07 Heinz Co Brands H J Llc Composições e métodos probióticos
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
US11446316B2 (en) 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN104023560A (zh) 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
US20140356340A1 (en) * 2011-12-15 2014-12-04 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
FR2984352B1 (fr) * 2011-12-16 2018-02-16 Lesaffre Et Compagnie Composition comprenant une biomasse microbienne active
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
CN102715235B (zh) * 2012-07-10 2013-09-11 武汉光明乳品有限公司 一种活性植物乳杆菌饮品及其制备方法
CN102949416B (zh) * 2012-11-23 2018-12-11 西安泰科迈医药科技股份有限公司 一种用于改善胃肠道功能的药物组合物及其制备方法
US20150290258A1 (en) 2012-11-29 2015-10-15 Nestec S.A. Synbiotic composition and use thereof
CN103006825A (zh) * 2012-12-21 2013-04-03 林树芳 一种辅助治疗胃病疾患的药膳食品
FR2999933B1 (fr) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999932B1 (fr) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
KR102182938B1 (ko) * 2012-12-28 2020-11-25 가부시키가이샤 엘에스아이 메디엔스 위험의 계층화, 진단 및 예후를 위한 sCD14 또는 그의 단편 또는 유도체의 사용
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2014125099A1 (en) * 2013-02-15 2014-08-21 Nestec S.A. Food composition and its use
BR112015020855A2 (pt) 2013-03-15 2017-07-18 Smith & Nephew curativo para ferida e método de tratamento
EP2988615B1 (en) * 2013-03-28 2019-10-02 Fresenius Kabi Deutschland GmbH Compositions for use in nutrition of dysphagia patients
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN104120093B (zh) * 2013-04-26 2016-12-28 中国农业大学 长双歧杆菌及其应用以及功能食品组合物及其制备方法
EP3470074B1 (en) 2013-05-10 2020-10-14 H.J. Heinz Company Brands LLC Probiotics
WO2015021936A1 (en) * 2013-08-16 2015-02-19 The University Of Hong Kong Method and compositions for treating cancer using probiotics cross-reference to related application
CN103621633B (zh) * 2013-12-05 2015-02-04 刘保惠 一种婴幼儿系列牦牛奶配方奶粉及其制备方法
JPWO2015087919A1 (ja) * 2013-12-10 2017-03-16 株式会社明治 抗菌ペプチド誘導剤
CN103636779A (zh) * 2013-12-17 2014-03-19 山东兴牛乳业有限公司 一种功能性发酵乳及其制备方法
FR3020949B1 (fr) * 2014-05-16 2018-02-09 Ecole Normale Superieure De Lyon Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition
CN105176857B (zh) * 2014-06-12 2019-02-12 暨南大学 具有氨苄青霉素抗性的长双歧杆菌及其制剂的制备与应用
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
PL3193901T3 (pl) 2014-12-23 2018-10-31 4D Pharma Research Limited Polipeptyd pyrynowy i immunomodulacja
CN113862175A (zh) 2014-12-23 2021-12-31 4D制药研究有限公司 免疫调控
TWI759260B (zh) 2015-01-02 2022-04-01 美商梅拉洛伊卡公司 多元補充品組成物
US10137164B2 (en) 2015-01-02 2018-11-27 Melaleuca, Inc. Dietary supplement compositions
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物
JP6666053B2 (ja) * 2015-03-31 2020-03-13 雪印メグミルク株式会社 Ｉａｌｄ産生促進剤
CN104770469A (zh) * 2015-04-17 2015-07-15 武汉百信正源生物技术工程有限公司 一种具有增强免疫力功能的酸驴奶的制备方法
WO2016177797A1 (en) 2015-05-06 2016-11-10 Wageningen Universiteit Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
JP6865682B2 (ja) * 2015-05-29 2021-04-28 株式会社明治 抗う蝕剤及び抗う蝕用組成物
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MD3206700T2 (ro) 2015-06-15 2019-12-31 4D Pharma Res Ltd Compoziții conținând tulpini bacteriene
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
CN105166633A (zh) * 2015-07-20 2015-12-23 龚启萍 一种添加益生菌的婴儿米粉的加工方法
BR112018000934B1 (pt) * 2015-08-31 2022-02-01 Société des Produits Nestlé S.A. Usos de bifidobacterium longum para tratar ou prevenir sintomas depressivos
ES3031514T3 (en) 2015-09-10 2025-07-09 Univ Catholique Louvain Use of pasteurized akkermansia for treating cancer
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US20170079310A1 (en) * 2015-09-18 2017-03-23 Richard Gerry Dingman, JR. Texture analog dysphagia cuisine
US11235010B2 (en) 2015-10-07 2022-02-01 Galderma Research & Development Composition containing lactic acid bacteria and its use to treat atopic dermatitis
WO2017085520A1 (en) 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3173373A1 (en) 2015-11-26 2017-05-31 Anheuser-Busch InBev S.A. Polymeric keg connector
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN107007632B (zh) * 2016-01-28 2022-05-06 康贝株式会社 用于改善或预防疱疹病毒感染症的组合物
CN105661017A (zh) * 2016-02-03 2016-06-15 程雪娇 一种牲畜饲料及制备方法
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
JP6441536B2 (ja) 2016-03-04 2018-12-19 フォーディー ファーマ ピーエルシー４Ｄ Ｐｈａｒｍａ Ｐｌｃ 細菌株を含む組成物
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
JP6727051B2 (ja) * 2016-07-15 2020-07-22 学校法人 埼玉医科大学 増粘剤、組成物キット及び組成物を増粘させる方法
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
EP3533453B1 (en) * 2016-10-28 2025-04-09 Kabushiki Kaisha Yakult Honsha An agent comprising a lactic acid bacterium for use in reducing the risk of developing an eye disease or equilibrium dysfunction
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018109018A1 (fr) 2016-12-16 2018-06-21 Nestle Skin Health Sa Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions
WO2018151245A1 (ja) 2017-02-17 2018-08-23 株式会社 明治 インターロイキン－２３産生促進用組成物およびインターロイキン－２３の産生促進方法
JP6799673B2 (ja) * 2017-03-30 2020-12-16 森永乳業株式会社 炎症制御遺伝子の発現促進用組成物
CN107772264A (zh) * 2017-05-12 2018-03-09 南昌大学 一种具有排汞功能的南瓜果胶排汞婴幼儿米粉的制备方法
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
MA49010B1 (fr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
LT3600363T (lt) 2017-06-14 2021-02-10 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
FR3070167B1 (fr) * 2017-08-17 2021-12-24 Ecole Normale Superieure Lyon Souches de lactobacillus stimulant la croissance
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
JP7065589B2 (ja) 2017-10-31 2022-05-12 株式会社明治 ＩＬ－１β血清濃度低下用発酵乳、ＣＸＣＬ１血清濃度低下用発酵乳、癌に伴うＩＬ－１βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うＣＸＣＬ１の過度な血清濃度上昇の抑制用発酵乳
CN108013473B (zh) * 2017-11-20 2021-06-18 陕西海升果业发展股份有限公司 一种益生菌冻干块及制备方法以及基于该冻干块的即食水果谷物麦片及制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN108077935A (zh) * 2018-01-22 2018-05-29 广东格物生物科技有限公司 调理中老年人肠道功能菌剂及其制备方法和应用
JP6846376B2 (ja) * 2018-03-15 2021-03-24 キリンホールディングス株式会社 皮膚状態改善用組成物
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
CA3114973A1 (en) * 2018-10-02 2020-04-09 Societe Des Produits Nestle S.A. Probiotic combination for treatment of inflammatory-related gastrointestinal disorders
WO2020109559A1 (en) * 2018-11-29 2020-06-04 Rhodia Operations Use of guar gum in biofungicide compositions
WO2020113485A1 (zh) * 2018-12-06 2020-06-11 江苏安惠生物科技有限公司 调节肠道菌群的胶囊
BR112021013190A2 (pt) 2019-01-04 2021-09-28 Lactobio A/S Cepa bacteriana isolada, composição e uso de composição
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
TWI729384B (zh) * 2019-04-26 2021-06-01 大江生醫股份有限公司 泌尿生殖道保健之益生菌株及其用途
JP7013419B2 (ja) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
CN110777087B (zh) * 2019-08-09 2020-08-07 四川厌氧生物科技有限责任公司 一种约氏乳杆菌及其应用
CN110521938A (zh) * 2019-09-12 2019-12-03 广东金海康医学营养品股份有限公司 一种婴幼儿营养米粉及其制备方法
CN110638845B (zh) * 2019-11-08 2020-07-14 爱优诺营养品有限公司 一种菌剂组合物及其在改善厌食症功能性奶粉上的应用
KR102135879B1 (ko) * 2020-02-13 2020-07-21 주식회사 케이티앤지 신규 락토바실러스 플란타룸(Lactobacillus plantarum) KC3 균주를 이용한 면역장애, 호흡기 염증 질환, 알레르기 및 천식의 예방 또는 치료용 조성물 및 이의 용도
WO2022248900A1 (en) * 2021-05-27 2022-12-01 Compagnie Gervais Danone Cereal-based compositions with a mix of galacto-oligosaccharides/fructo- oligosaccharides and uses thereof for improving iron absorption
CN113025540B (zh) * 2021-05-28 2021-10-01 中国食品发酵工业研究院有限公司 用于发酵大豆蛋白的乳酸菌菌剂、制备方法、发酵方法、具有增肌功能的发酵产物
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota
CN115428954A (zh) * 2022-09-15 2022-12-06 北京三元食品股份有限公司 复合益生菌及发酵乳在制备用于辅助治疗hiv患者产品中的应用
EP4619504A1 (fr) 2022-11-17 2025-09-24 Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1
CN116064339B (zh) * 2023-03-10 2025-09-23 扬州大学 一株约氏乳酸杆菌n5及其在防治肠炎及腹泻上的应用
CN117946919B (zh) * 2024-01-23 2024-07-23 西南大学 乳脂乳球菌、发酵剂及其在制备米粉中的应用
CN118028182B (zh) * 2024-04-12 2024-06-18 四川厌氧生物科技有限责任公司 一种改善口腔健康的约翰逊氏乳杆菌及其用途

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456207A (en) * 1972-12-15 1976-11-24 Unilever Ltd Ice-cream
GB2225922B (en) 1988-12-16 1992-10-07 Samuel Kuria Mbugua A method for the manufacture of a fermented cereal product
US4980182A (en) 1989-06-21 1990-12-25 Nestec S.A. Beverages containing a beverage base and milk protein
ES2111625T3 (es) 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5494687A (en) * 1993-11-05 1996-02-27 Polster; Louis S. Process for tenderizing meat
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6194009B1 (en) * 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
DE19860375A1 (de) * 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
US6120814A (en) * 1999-02-22 2000-09-19 Nature's One, Inc. Organic nutritional formula
HK1046864B (zh) * 1999-03-11 2006-10-27 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
OA12074A (en) * 1999-10-26 2006-05-04 Nestle Sa Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
AU784898B2 (en) * 2000-01-18 2006-07-20 Societe Des Produits Nestle S.A. Pet food composition for treating helicobacter species in pets
EP1276488B1 (en) * 2000-03-24 2006-12-20 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the prevention of peritonitis
EP1273287A1 (en) * 2000-04-04 2003-01-08 Shionogi & Co., Ltd. Oily compositions containing highly fat-soluble drugs
NZ524527A (en) * 2000-09-25 2005-05-27 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
JP4510376B2 (ja) * 2000-10-06 2010-07-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 皮膚の免疫系のバランスを保つためのプロバイオティック乳酸菌の使用
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
RU2302747C2 (ru) 2001-02-19 2007-07-20 Сосьете Де Продюи Нестле С.А. Продукт питания из злаков, содержащий пробиотический микроорганизм, продукт питания из злаков, содержащий метаболиты, продуцированные пробиотическими микроорганизмами, и способы их получения
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1260227A1 (en) 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
DE60234038D1 (de) * 2001-08-02 2009-11-26 Simply Thick Llc Verfahren zur herstellung von konzentratverdickungszusammensetzungen
ATE325604T1 (de) * 2002-02-21 2006-06-15 Nestle Sa Oral verabreichbare zusammensetzung zum schutz der haut vor licht
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
CN1183960C (zh) * 2003-02-27 2005-01-12 四川大学 双歧杆菌细胞壁蛋白在制药中的应用
JP4038450B2 (ja) * 2003-03-31 2008-01-23 株式会社バイオテックジャパン 低カロリーご飯並びに低カロリー米及びそれらの製造方法
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
RU2346449C2 (ru) * 2003-06-23 2009-02-20 Нестек С.А. Смесь для детей первых месяцев жизни или старше
CN1870910B (zh) * 2003-10-24 2010-05-26 努特里奇亚有限公司 婴儿合生素组合物
US7510734B2 (en) 2004-03-04 2009-03-31 E-L Management Corporation Skin treatment method with Lactobacillus extract
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
CA2568650C (en) 2004-06-01 2010-04-13 Prophagia Inc. Index and method of use of adapted food compositions for dysphagic persons
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
JP5371169B2 (ja) * 2004-09-24 2013-12-18 コンビ株式会社 薬剤耐性菌感染防除剤
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
ATE394940T1 (de) * 2004-11-12 2008-05-15 Nutricia Nv Flüssige übergangsnahrung für kleinkinder
AU2004325038B2 (en) * 2004-11-18 2011-07-14 N.V. Nutricia Thickener composition for dysphagia patients
DE602006015438D1 (de) * 2005-02-15 2010-08-26 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
TR201820329T4 (tr) * 2005-02-28 2019-01-21 Nutricia Nv Probiyotik İçeren Besin Bileşimi
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
AU2006233918B2 (en) 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
WO2007009568A1 (en) * 2005-07-20 2007-01-25 Unilever N.V. Edible product containing beneficial bacteria
WO2007020884A1 (ja) * 2005-08-12 2007-02-22 Meiji Dairies Corporation β－ディフェンシンを介した感染予防効果を有するビフィズス菌または乳酸菌とそれを含有する食品・医薬品組成物
EP1940248B1 (en) * 2005-10-05 2009-12-16 Nestec S.A. Use of a nutritional formulation for promoting catch-up growth
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007050656A2 (en) * 2005-10-24 2007-05-03 Nestec S.A. Dietary fiber formulation and method of administration
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US7758906B2 (en) * 2006-01-20 2010-07-20 Kraft Foods Global Brands Llc Thickening system for products prepared with milk
CA2642431A1 (en) * 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
PL1993576T3 (pl) 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
EP1915913B1 (en) 2006-10-23 2015-11-18 Nestec S.A. Taste and flavour modulation by biotransformation in milk products
US9408818B2 (en) * 2007-02-28 2016-08-09 Mead Johnson Nutrition Company Method for the utilization of and product containing inactivated probiotic
WO2008137181A1 (en) * 2007-05-07 2008-11-13 Clearly Superior, Inc Food thickening agent, method for producing food thickening agent
EP1992351B1 (en) 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
JP2008283922A (ja) * 2007-05-18 2008-11-27 Fuji Oil Co Ltd ヨーグルト様飲食品の製造法
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009005107A1 (ja) * 2007-07-02 2009-01-08 San-Ei Gen F.F.I., Inc. デキストリンを含有する加工食品組成物
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
AU2008333718B2 (en) * 2007-12-06 2012-03-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
US9119414B2 (en) 2007-12-07 2015-09-01 N.V. Nutricia Bifidobacterium for dust mite allergy
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
ES2395838T3 (es) * 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
US20090162499A1 (en) * 2007-12-21 2009-06-25 The Quaker Oats Company Grain products having a potent natural sweetener and a bulking agent
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
US20120039860A1 (en) * 2008-04-10 2012-02-16 Nestec S.A. Compositions and methods for improved oral health
WO2009151330A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2140772A1 (en) 2008-07-03 2010-01-06 Nestec S.A. Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
JP2010095465A (ja) * 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
EP2438821B1 (en) * 2008-11-03 2020-01-15 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
EP2251021B1 (en) 2009-05-11 2012-02-22 Nestec S.A. Prevention and treatment of allergic diarrhoea
EP2251022A1 (en) 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
US8784798B2 (en) 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2251020A1 (en) 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
BR112012013766A2 (pt) 2009-12-08 2015-09-15 Nestec Sa "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite"
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물

Also Published As

Publication number Publication date
US20120121685A1 (en) 2012-05-17
RU2011150197A (ru) 2013-06-20
BRPI1010929A2 (pt) 2016-04-05
US20130260440A1 (en) 2013-10-03
CA2761672A1 (en) 2011-01-06
CA2761689A1 (en) 2010-11-18
JP2012526529A (ja) 2012-11-01
ES2576831T3 (es) 2016-07-11
MX2011012070A (es) 2012-03-07
US20120269789A1 (en) 2012-10-25
US8691244B2 (en) 2014-04-08
ES2572760T3 (es) 2016-06-02
JP2012526528A (ja) 2012-11-01
MY173382A (en) 2020-01-21
US20120114701A1 (en) 2012-05-10
JP2012526760A (ja) 2012-11-01
CN102802648A (zh) 2012-11-28
CN103052395A (zh) 2013-04-17
JP2012526751A (ja) 2012-11-01
RU2011150214A (ru) 2013-06-20
WO2010130701A1 (en) 2010-11-18
US9375454B2 (en) 2016-06-28
RU2549934C2 (ru) 2015-05-10
AR076677A1 (es) 2011-06-29
JP2012526758A (ja) 2012-11-01
RU2556124C2 (ru) 2015-07-10
EP2429538B1 (en) 2015-10-21
MX2011012074A (es) 2012-03-07
BRPI1010912A2 (pt) 2019-09-24
EP2429557A2 (en) 2012-03-21
TWI489988B (zh) 2015-07-01
US20120189598A1 (en) 2012-07-26
CA2761446A1 (en) 2010-11-18
US20150079056A1 (en) 2015-03-19
PT2429539T (pt) 2017-01-12
MX341685B (es) 2016-08-30
MY166552A (en) 2018-07-16
WO2010142504A1 (en) 2010-12-16
WO2010139531A1 (en) 2010-12-09
EP2429556B1 (en) 2016-03-30
CN102770145A (zh) 2012-11-07
MX2011012075A (es) 2012-03-07
ZA201109095B (en) 2015-06-24
RU2554772C2 (ru) 2015-06-27
EP2429548A1 (en) 2012-03-21
EP2429553A1 (en) 2012-03-21
US8784798B2 (en) 2014-07-22
AU2010255972A1 (en) 2011-12-08
CN102858354A (zh) 2013-01-02
CN103596578A (zh) 2014-02-19
BRPI1010637A2 (pt) 2019-04-02
RU2011150195A (ru) 2013-06-20
CA2761573A1 (en) 2010-11-18
MY159273A (en) 2016-12-30
CA2761453A1 (en) 2010-11-25
CL2011002818A1 (es) 2012-05-11
US20120183514A1 (en) 2012-07-19
EP2429543A1 (en) 2012-03-21
CN102695519A (zh) 2012-09-26
RU2011150202A (ru) 2013-06-20
WO2010133475A2 (en) 2010-11-25
WO2010130702A1 (en) 2010-11-18
US8603492B2 (en) 2013-12-10
SG175167A1 (en) 2011-11-28
US20120135044A1 (en) 2012-05-31
WO2011000621A1 (en) 2011-01-06
TW201043238A (en) 2010-12-16
CN102595916A (zh) 2012-07-18
CA2761691A1 (en) 2010-11-18
MX338680B (es) 2016-04-27
EP2429539B1 (en) 2016-10-12
JP2016006054A (ja) 2016-01-14
US20120141444A1 (en) 2012-06-07
EP2429546B1 (en) 2016-08-31
ES2559008T3 (es) 2016-02-10
JP2012526756A (ja) 2012-11-01
US20120183515A1 (en) 2012-07-19
WO2010130662A1 (en) 2010-11-18
EP2429556A2 (en) 2012-03-21
US20120128726A1 (en) 2012-05-24
AU2010247469B2 (en) 2014-12-18
CN102917714A (zh) 2013-02-06
CA2761598A1 (en) 2010-11-18
EP2429540B1 (en) 2016-07-27
BRPI1010574A2 (pt) 2016-03-15
TW201100087A (en) 2011-01-01
WO2010130713A1 (en) 2010-11-18
JP2013526265A (ja) 2013-06-24
BRPI1010802A2 (pt) 2016-04-05
BRPI1010926A2 (pt) 2016-04-05
CA2761655A1 (en) 2010-11-18
JP2012526762A (ja) 2012-11-01
MY165388A (en) 2018-03-21
AU2010247469A1 (en) 2011-12-08
AU2010251313A1 (en) 2011-11-17
CA2761687A1 (en) 2010-11-18
CA2761574A1 (en) 2010-11-18
CN103648510A (zh) 2014-03-19
JP2012526754A (ja) 2012-11-01
RU2011150216A (ru) 2013-06-20
BRPI1010838A2 (pt) 2019-09-24
EP2429538A1 (en) 2012-03-21
ES2608651T3 (es) 2017-04-12
MX2011012063A (es) 2011-12-06
EP2429552A1 (en) 2012-03-21
CN102811725A (zh) 2012-12-05
JP5860396B2 (ja) 2016-02-16
AR076676A1 (es) 2011-06-29
EP2429550A1 (en) 2012-03-21
CA2761444A1 (en) 2010-11-18
EP2429540A1 (en) 2012-03-21
CN102939093A (zh) 2013-02-20
US20120195867A1 (en) 2012-08-02
PL2429557T3 (pl) 2018-06-29
WO2011000620A1 (en) 2011-01-06
JP2012526759A (ja) 2012-11-01
US8916374B2 (en) 2014-12-23
RU2564139C2 (ru) 2015-09-27
BRPI1013733A2 (pt) 2019-09-24
US8802077B2 (en) 2014-08-12
CN102844037A (zh) 2012-12-26
PL2429556T3 (pl) 2017-01-31
WO2010130700A1 (en) 2010-11-18
BRPI1012849A2 (pt) 2018-06-19
ZA201109091B (en) 2013-05-29
WO2010133475A3 (en) 2011-01-27
EP2429557B1 (en) 2016-05-04
ZA201109085B (en) 2013-05-29
RU2539852C2 (ru) 2015-01-27
JP2012526757A (ja) 2012-11-01
WO2010130710A1 (en) 2010-11-18
US20120121561A1 (en) 2012-05-17
UA109876C2 (uk) 2015-10-26
EP2429546A1 (en) 2012-03-21
US20120064051A1 (en) 2012-03-15
CN102762216A (zh) 2012-10-31
MX2011012067A (es) 2011-12-06
JP2012526761A (ja) 2012-11-01
CN102858354B (zh) 2015-06-17
BRPI1014304A2 (pt) 2016-04-05
BRPI1010919A2 (pt) 2019-09-24
CA2761444C (en) 2018-04-24
CA2761449A1 (en) 2010-11-18
WO2010133472A3 (en) 2011-02-03
JP2013526480A (ja) 2013-06-24
CN104220082A (zh) 2014-12-17
EP2429554A1 (en) 2012-03-21
EP2429541A1 (en) 2012-03-21
CN102869365A (zh) 2013-01-09
EP2429549A1 (en) 2012-03-21
EP2429551A1 (en) 2012-03-21
ZA201109093B (en) 2013-05-29
WO2010133472A2 (en) 2010-11-25
BRPI1010836A2 (pt) 2016-04-05
WO2010130704A1 (en) 2010-11-18
MX2011012064A (es) 2011-12-06
MX339112B (es) 2016-05-12
JP2012526755A (ja) 2012-11-01
EP2429557B2 (en) 2024-05-22
EP2429539A1 (en) 2012-03-21
WO2010130697A1 (en) 2010-11-18
BRPI1010839A2 (pt) 2016-04-05
TWI402075B (zh) 2013-07-21
EP2429545A1 (en) 2012-03-21
US20120107287A1 (en) 2012-05-03
MX2011012066A (es) 2012-03-07
CN102883731A (zh) 2013-01-16
BRPI1010917A2 (pt) 2016-03-15
WO2010130699A1 (en) 2010-11-18
US10576110B2 (en) 2020-03-03
PT2429557E (pt) 2016-06-17
RU2011150192A (ru) 2013-06-20
BRPI1010916A2 (pt) 2019-09-24
US20120121652A1 (en) 2012-05-17
MX336030B (es) 2016-01-07
US20130028877A1 (en) 2013-01-31
WO2010130663A1 (en) 2010-11-18
US20120121563A1 (en) 2012-05-17
JP2012526752A (ja) 2012-11-01

Similar Documents

Publication Publication Date Title
BRPI1013731A2 (pt) leite de crescimento contendo micro-organismos probioticos
DK2473116T3 (da) Knoglevækstindretning
PT3509341T (pt) Adaptação de parâmetros de transferência
EP2478086A4 (en) PHOTOBIOREACTOR FOR BREADING ALGAE
DK2440647T3 (da) Mikrokapsler indeholdende mikroorganismer
GB0905611D0 (en) Bioreactor
EP2516615A4 (en) IMPROVED BIOREACTORS
EP2326717A4 (en) ON THE BASIS OF ULTRASONIC REINFORCED GROWTH OF MICROORGANISMS
GB0911380D0 (en) Maritube - floating algal cultivation system
GB201004101D0 (en) Immobilised biological entities
GB0916957D0 (en) Floagal-floating algal cultivation system
IT1394412B1 (it) Procedimento per l'essiccazione di biomassa algale
ZA201108490B (en) Fermentation
BRPI0911135A2 (pt) nutriente enteral
ZA201200430B (en) Diphasic algal culture system
PL2263445T3 (pl) Grupa doniczek
FIU20090481U0 (fi) Maitohappobakteereja sisältävä täydennysrehu
HK1168547A (en) Growing up milks containing probiotic micro-organisms
TH102346B (th) ขวดนม
TH102347B (th) ขวดนม
GB0906305D0 (en) Culture
GB0906303D0 (en) Culture
GB0906308D0 (en) Culture
GB0906309D0 (en) Culture
GB0906311D0 (en) Culture

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.